ISSN: 1757-6180

Journal Home

Journal Guideline

Bioanalysis Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Bioanalysis is a journal indexed in SJR in Medicine (miscellaneous) and Analytical Chemistry with an H index of 70. It has an SJR impact factor of 0,43 and it has a best quartile of Q2. It has an SJR impact factor of 0,43.

Bioanalysis focuses its scope in these topics and keywords: bioanalysis, quantitation, biological, method, msms, drugs, emerging, endogenous, dried, analysisvolatile, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medical Laboratory Technology (Q2) Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2) Analytical Chemistry (Q3) Clinical Biochemistry (Q3) Medicine (miscellaneous) (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,43

SJR Impact factor

70

H Index

121

Total Docs (Last Year)

442

Total Docs (3 years)

4027

Total Refs

742

Total Cites (3 years)

402

Citable Docs (3 years)

1.63

Cites/Doc (2 years)

33.28

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Proteomics of drug-resistant cancer biomarkers

The 5th Annual Shanghai Symposium on Clinical & Pharmaceutical Solutions through Analysis

Recent advances in hydrophilic interaction chromatography for quantitative analysis of endogenous and pharmaceutical compounds in plasma samples

Quantitative immunocapture MS: current status and challenges in drug discovery

Untargeted profiling of urinary steroid metabolites after testosterone ingestion: opening new perspectives for antidoping testing

Breath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis

An ultra-sensitive clinical biomarker assay: quantitation of thymus and activation-regulated chemokine in human plasma

Metabolomics of drugs of abuse: a more realistic view of the toxicological complexity

A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species

7th GCC Insights: incurred samples use; fit-for-purpose validation, solution stability, electronic laboratory notebook and hyperlipidemic matrix testing

Hair: a complementary source of bioanalytical information in forensic toxicology

Forensic and clinical toxicology

SHOW MORE ARTICLES

Nonclinical immunogenicity risk assessment of therapeutic proteins

Label-free MS imaging from drug discovery to preclinical development

A multiplexed hybrid LC-MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical study

Paper spray-MS for bioanalysis

Recent advances in MS methods for nicotine and metabolite analysis in human matrices: clinical perspectives

Determination of eniluracil and 5-fluorouracil in human plasma by LC-MS/MS

Matrix effect and recovery terminology issues in regulated drug bioanalysis

An optimal LC-MS/MS method for determination of azithromycin in white blood cells: application to pediatric samples

Methods for urine drug testing using one-step dilution and direct injection in combination with LC-MS/MS and LC-HRMS

Feedback from the European Bioanalysis Forum Workshop: taking tiered approach to the next level

Reducing pre-clinical blood volumes for toxicokinetics: toxicologists, pathologists and bioanalysts unite

2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1 -small molecules by LCMS)